As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]
FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age – December 9, 2022 Dear COVID-19 Vaccination Provider: On December 8, 2022, FDA authorized the bivalent Moderna COVID-19 vaccine for children ages 6 months through 5 years of age and bivalent Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4
-
As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]
-
As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]
Updated Clinical Guidance For Individuals 6 Months-11 Years Old – June 22, 2022 Dear NYS COVID-19 Vaccine Provider: Effective June 18, 2022, the CDC has recommended that everyone ages 6 months and older in the United States should receive a COVID-19 primary series vaccination for the prevention of COVID-19. This attached provider guidance has
Updated Guidance for The New York State COVID-19 Vaccination Program for Individuals 12 Years of Age or Older June 13, 2022 Note: This guidance document applies specifically to health care providers offering COVID-19 vaccinations to adolescents and adults ages 12 and older. Guidance specific to COVID-19 vaccination of children ages 5-11 can be found
The FDA amended the emergency use authorizations for COVID-19 vaccines today as follows: A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
Dear NYS COVID-19 Vaccine Provider: On January 7, 2022, the CDC updated the recommendation for receipt of a booster dose of the COVID-19 vaccine following receipt of the Moderna primary series. CDC now recommends receipt of a booster dose at least five months after completing their Moderna primary series. This previously recommended interval was at
Updated Information from CDC on COVID-19 Vaccine for Individuals who Received Primary Vaccination Not Approved/Authorized in the US The CDC recently updated the Emergency Use Instructions (EUI) and clinical guidance for persons who received primary vaccination with vaccines not approved/authorized in the U.S. The updated EUI and clinical guidance state that individuals who received an
